ISMD
Inspire Small/Mid Cap ETF
The Inspire Small/Mid Cap Impact ETF tracks an equal-weighted index of 500 small- and midcap US stocks that are screened for alignment with biblical values and positive impact on the world according to various ESG criteria.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 317.4 M
ASSETS UNDER MGMT
54 bp
EXPENSES
Fund Basics
| Inception date | Feb 27, 2017 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| TWIST BIOSCIENCE CORP. | 0.4 % |
| AMPLITUDE INC CLASS A | 0.4 % |
| UTZ BRANDS INC CLASS A | 0.4 % |
| TASKUS INC CLASS A | 0.4 % |
| EMBECTA CORPORATION | 0.4 % |
| VAREX IMAGING CORPORATION | 0.4 % |
| PULSE BIOSCIENCES, INC. | 0.4 % |
| CBIZ INC | 0.4 % |
| VIA TRANSPORTATION INC ORDINARY SHARES - | 0.3 % |
| KARAT PACKAGING, INC. | 0.3 % |
Constituent Breakdown
| Number of holdings | 503 |
| Herfindahl-Hirschman Index | 26 |
| Wgt avg mkt cap (mns) | $2,593 |
| Large cap (>$10bn) | 3.3% |
| Mid cap ($2-10bn) | 45.9% |
| Small cap (<$2bn) | 42.6% |
| Developed mkts. | 91.8% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 92.5 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 20.1% | 19.3% | 10.6% | 15.1% | 5.5% | -- | -- | 6.7% |
| Dividend Yield | 1.5% | 1.8% | 1.5% | 1.6% | 3.2% | -- | -- | 2.6% |
| Total Returns | 21.6% | 21.1% | 12.1% | 16.7% | 8.7% | -- | -- | 9.3% | Ann. Volatility | 16.9% | 17.3% | 19.8% | 19.8% | 20.7% | -- | -- | 23.5% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.97 | 52% |
| MSCI EAFE | 0.74 | 46% |
| MSCI Emg Mkts | 0.40 | 35% |
Liquidity Measures
| Avg. volume (000) | 27 |
| ADV traded (mns) | $1 |
| Turnover | 0.4% |
| Avg. Bid/Ask (% of price) | 0.25% |
Technical Indicators
| 30d moving avg. (EMA) | $49.52 |
| Relative strength (RSI) | 61 |
| MACD/Signal | 0.45/0.40 |
| Bollinger Bands (Upper/Lower) | $50.94/$48.46 |
| Short interest (% of AUM) | 1.2% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. ISMD |
Expenses vs. ISMD |
ALTAR Score™ vs. ISMD |
|---|---|---|---|---|
| JPSE | JPMorgan Diversified Return U.S. Small Cap Equity ETF | 32.4% | -25 bp | +1.1% |
| AVSC | Avantis U.S Small Cap Equity ETF | 31.6% | -29 bp | -0.4% |
| TPSC | Timothy Plan US Small Cap Core ETF | 29.8% | -2 bp | +1.0% |
| RSSL | Global X Russell 2000 ETF | 29.5% | -46 bp | -3.2% |
| IWM | iShares Russell 2000 ETF | 29.4% | -35 bp | -3.2% |
| IWN | iShares Russell 2000 Value ETF | 29.1% | -30 bp | -0.7% |
| VTWO | Vanguard Russell 2000 ETF | 29.0% | -47 bp | -3.1% |
| VTWV | Vanguard Russell 2000 Value ETF | 29.0% | -44 bp | -0.5% |
| GSSC | Goldman Sachs Activebeta U.S. Small Cap Equity ETF | 28.8% | -34 bp | -2.1% |
| CSA | VictoryShares US Small Cap Volatility Wtd ETF | 28.7% | -19 bp | +0.8% |
Risk and Returns: ISMD vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 10/16/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.2%
ALTAR SCORE™
63rd
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,394 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.2%. ISMD's ALTAR Score™ is approximately 0.3 standard
deviations above the category average. This places ISMD in the 63rd percentile
among funds in the category.
Sell-Side Consensus
$60.85
PRICE TARGET
+31.7%
UPSIDE